Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 103611 - 103620 of 167129 results

First page
Previous page
Next page
Next page

FISH LIVER OIL

BN5IO4652Q

Status:

Discontinued

Source:

Formula F L W by Creative Nutrition Canada Corp. [Canada]

Source URL:

https://www.drugbank.ca/drugs/DB15481

Class:

MIXTURE

POTASSIUM GUAIACOLSULFONATE ANHYDROUS

21A795TNZD

Status:

Discontinued

Source:

Phenylephrine Carbetapentane Potassium Guaiacolsulfonate by River's Edge Pharmaceuticals, LLC

Source URL:

https://www.drugbank.ca/drugs/DB13735

Class:

MIXTURE

TECHNETIUM TC-99M CATION, UNSPECIFIED

2JR2CU14D2

Status:

Discontinued

Source:

NDA018107

Source URL:

https://www.drugbank.ca/drugs/DB09138

Class:

MIXTURE

Datopotamab Deruxtecan

GD2OWY1DTK

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

US Approved Rx (2025)

Source:

BLA761394

(2025)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761394

First approved in 2025

Source:

BLA761394

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761394

Class:

PROTEIN

MARSTACIMAB

0UB3OA67O7

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

US Approved Rx (2024)

Source:

BLA761369

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761369

First approved in 2024

Source:

BLA761369

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761369

Class:

PROTEIN

PEGULICIANINE ACETATE

F3F6208UMT

Subunit 1 (6) Similarity Search

Sequence Search

Subunit 1 (6) Similarity Search

Status:

US Approved Rx (2024)

Source:

NDA214511

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214511

First approved in 2024

Source:

NDA214511

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214511

Class:

PROTEIN

PALOPEGTERIPARATIDE

G2N64C3385

Subunit 1 (34) Similarity Search

Sequence Search

Subunit 1 (34) Similarity Search

Status:

US Approved Rx (2024)

Source:

NDA216490

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216490

First approved in 2024

Source:

NDA216490

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216490

Class:

PROTEIN

Zolbetuximab

TF5MPQ8WGY

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

US Approved Rx (2024)

Source:

BLA761365

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761365

First approved in 2024

Source:

BLA761365

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7695a21-abb6-47ac-93f8-0ece5a9c4409

Class:

PROTEIN

Donanemab

1ADB65P1KK

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

US Approved Rx (2024)

Source:

BLA761248

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761248

First approved in 2024

Source:

BLA761248

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761248

Class:

PROTEIN

Cosibelimab

PNW7GBB44P

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

US Approved Rx (2024)

Source:

BLA761297

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761297

First approved in 2024

Source:

BLA761297

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761297

Class:

PROTEIN

Mixture

Mixture

POTASSIUM GUAIACOLSULFONATE ANHYDROUS

Mixture

TECHNETIUM TC-99M CATION, UNSPECIFIED

Protein

Datopotamab Deruxtecan

Protein

Protein

PEGULICIANINE ACETATE

Protein

PALOPEGTERIPARATIDE

Protein

Protein

Protein

Showing 103611 - 103620 of 167129 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1